Home/Filings/4/0000899243-18-025346
4//SEC Filing

Lopez Fabio 4

Accession 0000899243-18-025346

CIK 0001390478other

Filed

Sep 25, 8:00 PM ET

Accepted

Sep 26, 7:43 PM ET

Size

22.8 KB

Accession

0000899243-18-025346

Insider Transaction Report

Form 4
Period: 2018-09-24
Transactions
  • Other

    Common Stock

    2018-09-241,521,8630 total
  • Other

    Common Stock

    2018-09-24325,7990 total
  • Other

    Common Stock

    2018-09-24676,3240 total
Lopez Fabio
Director10% Owner
Transactions
  • Other

    Common Stock

    2018-09-241,521,8630 total
  • Other

    Common Stock

    2018-09-24676,3240 total
  • Other

    Common Stock

    2018-09-24325,7990 total
Transactions
  • Other

    Common Stock

    2018-09-24676,3240 total
  • Other

    Common Stock

    2018-09-241,521,8630 total
  • Other

    Common Stock

    2018-09-24325,7990 total
Transactions
  • Other

    Common Stock

    2018-09-241,521,8630 total
  • Other

    Common Stock

    2018-09-24325,7990 total
  • Other

    Common Stock

    2018-09-24676,3240 total
Transactions
  • Other

    Common Stock

    2018-09-241,521,8630 total
  • Other

    Common Stock

    2018-09-24325,7990 total
  • Other

    Common Stock

    2018-09-24676,3240 total
Transactions
  • Other

    Common Stock

    2018-09-24676,3240 total
  • Other

    Common Stock

    2018-09-24325,7990 total
  • Other

    Common Stock

    2018-09-241,521,8630 total
Transactions
  • Other

    Common Stock

    2018-09-241,521,8630 total
  • Other

    Common Stock

    2018-09-24325,7990 total
  • Other

    Common Stock

    2018-09-24676,3240 total
Transactions
  • Other

    Common Stock

    2018-09-241,521,8630 total
  • Other

    Common Stock

    2018-09-24325,7990 total
  • Other

    Common Stock

    2018-09-24676,3240 total
Tafur Daniel
10% Owner
Transactions
  • Other

    Common Stock

    2018-09-241,521,8630 total
  • Other

    Common Stock

    2018-09-24325,7990 total
  • Other

    Common Stock

    2018-09-24676,3240 total
Footnotes (6)
  • [F1]EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund ("Sely S") distributed 1,521,863 shares to its partners on a pro rata basis, for no consideration.
  • [F2]As a partner of Sely S, Fabio Lopez, received 19,524 of the shares distributed by Sely S.
  • [F3]EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund ("Sely I") distributed 676,324 shares to its partners on a pro rata basis, for no consideration.
  • [F4]As partners of Sely I, Daniel Tafur and Equilibria Capital Management received 13,871 and 107,619, respectively, of the shares distributed by Sely I.
  • [F5]EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund ("Sely II") distributed 325,799 shares to its partners on a pro rata basis, for no consideration.
  • [F6]As partners of Sely II, Fabio Lopez and Daniel Tafur received 6,325 and 2,372, respectively, of the shares distributed by Sely II.

Issuer

SELLAS Life Sciences Group, Inc.

CIK 0001390478

Entity typeother

Related Parties

1
  • filerCIK 0001724449

Filing Metadata

Form type
4
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 7:43 PM ET
Size
22.8 KB